<SEC-DOCUMENT>0001628280-25-004542.txt : 20250210
<SEC-HEADER>0001628280-25-004542.hdr.sgml : 20250210
<ACCEPTANCE-DATETIME>20250210100913
ACCESSION NUMBER:		0001628280-25-004542
CONFORMED SUBMISSION TYPE:	IRANNOTICE
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250210
DATE AS OF CHANGE:		20250210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVO NORDISK A S
		CENTRAL INDEX KEY:			0000353278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		IRANNOTICE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-82318
		FILM NUMBER:		25604053

	BUSINESS ADDRESS:	
		STREET 1:		NOVO ALLE DK 2880
		CITY:			BAGSVAERD DENMARK
		STATE:			G7
		ZIP:			00000
		BUSINESS PHONE:		4544448888

	MAIL ADDRESS:	
		STREET 1:		NOVO ALLE DK 2880
		CITY:			BAGSVAERD DENMARK
		STATE:			G7
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVO NORDISK A/S
		DATE OF NAME CHANGE:	19900807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVO INDUSTRI A S /DENMARK/
		DATE OF NAME CHANGE:	19890811
</SEC-HEADER>
<DOCUMENT>
<TYPE>IRANNOTICE
<SEQUENCE>1
<FILENAME>irannotice2024.htm
<DESCRIPTION>IRANNOTICE
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7deb2607f85a4ebfa56ad09cc721eb5f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Securities and Exchange Commission</font></div><div><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 F Street, N.E.</font></div><div><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</font></div><div><font><br></font></div><div style="margin-bottom:2pt"><font><br></font></div><div style="margin-bottom:2pt;text-align:right"><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;February 5, 2025&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:2pt"><font><br></font></div><div><font style="color:#000000;font-family:'Apis Medium',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Re&#58; Notice of disclosure filed in Exchange Act Annual Report under Section&#160;219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section&#160;13(r)&#160;of the Exchange Act</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Sirs,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section&#160;13(r)&#160;of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Novo Nordisk A&#47;S has made disclosure pursuant to those provisions in its Annual Report on Form&#160;20-F for the year ended December&#160;31, 2024, which was filed with the Securities and Exchange Commission on February 5, 2025.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Sincerely,</font></div><div><font><br></font></div><div style="margin-bottom:2pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:45.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.250%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Lars Fruergaard J&#248;rgensen</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Karsten Munk Knudsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lars Fruergaard J&#248;rgensen<br>President and chief executive officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br></font><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karsten Munk Knudsen<br>Executive vice president and <br>chief financial officer</font></td></tr></table></div><div style="margin-bottom:2pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
